Existing drugs as broad-spectrum and potent inhibitors for Zika virus by targeting NS2B-NS3 interaction
Existing drugs as broad-spectrum and potent inhibitors for Zika virus by targeting NS2B-NS3 interaction is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Existing drugs as broad-spectrum and potent inhibitors for Zika virus by targeting NS2B-NS3 interaction have?
Existing drugs as broad-spectrum and potent inhibitors for Zika virus by targeting NS2B-NS3 interaction has 216 citations in the OpenAlex counts ScholarIQ stores.
When was Existing drugs as broad-spectrum and potent inhibitors for Zika virus by targeting NS2B-NS3 interaction published?
Existing drugs as broad-spectrum and potent inhibitors for Zika virus by targeting NS2B-NS3 interaction has 2017 year in the ScholarIQ index.
What is the open-access status of Existing drugs as broad-spectrum and potent inhibitors for Zika virus by targeting NS2B-NS3 interaction?
Existing drugs as broad-spectrum and potent inhibitors for Zika virus by targeting NS2B-NS3 interaction has bronze oa status in the ScholarIQ index.
What is the DOI of Existing drugs as broad-spectrum and potent inhibitors for Zika virus by targeting NS2B-NS3 interaction?
The DOI for Existing drugs as broad-spectrum and potent inhibitors for Zika virus by targeting NS2B-NS3 interaction is on the source record.
What is the PMID of Existing drugs as broad-spectrum and potent inhibitors for Zika virus by targeting NS2B-NS3 interaction?
The PMID for Existing drugs as broad-spectrum and potent inhibitors for Zika virus by targeting NS2B-NS3 interaction is on the source record.
What is the OpenAlex record for Existing drugs as broad-spectrum and potent inhibitors for Zika virus by targeting NS2B-NS3 interaction?
The OpenAlex for Existing drugs as broad-spectrum and potent inhibitors for Zika virus by targeting NS2B-NS3 interaction is on the source record.